| Dr Kristophe Jemel Karami, DO, MS | |
|
601 N Caroline St, Baltimore, MD 21287-0006 | |
| (410) 955-6406 | |
| Not Available |
| Full Name | Dr Kristophe Jemel Karami |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 18 Years |
| Location | 601 N Caroline St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902929714 | NPI | - | NPPES |
| 054890100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | H73704 (Maryland) | Secondary |
| 207T00000X | Neurological Surgery | DO162805 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Sunnyside Medical Center | Clackamas, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the Parenteral Drug Association today announced the publication of Quality by Design: Putting Theory into Practice, written to help companies maximize product quality and safety. As increasing regulatory pressure is being placed on biopharmaceutical companies to be accountable for Quality Systems, the book serves as a definitive source on the interpretation and implementation of Quality by Design approaches.
In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons, researchers sought to evaluate the clinical, radiographic and functional outcomes of a Charnley total hip replacement (THR)─ a traditional hip prosthesis consisting of a polyethylene acetabular (plastic) cup and a metal femoral head─in patients under age 50 at a minimum of 35 years after the initial surgery.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its subsidiary, Biospherics Incorporated, has been awarded $469,479 under HR: 3590 – Patient Protection and Affordable Care Act in immediately available funds.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 4 days ago
| Entity Name | Legacy Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902827272 PECOS PAC ID: 0244144004 Enrollment ID: O20031117000089 |
News Archive
Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the Parenteral Drug Association today announced the publication of Quality by Design: Putting Theory into Practice, written to help companies maximize product quality and safety. As increasing regulatory pressure is being placed on biopharmaceutical companies to be accountable for Quality Systems, the book serves as a definitive source on the interpretation and implementation of Quality by Design approaches.
In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons, researchers sought to evaluate the clinical, radiographic and functional outcomes of a Charnley total hip replacement (THR)─ a traditional hip prosthesis consisting of a polyethylene acetabular (plastic) cup and a metal femoral head─in patients under age 50 at a minimum of 35 years after the initial surgery.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its subsidiary, Biospherics Incorporated, has been awarded $469,479 under HR: 3590 – Patient Protection and Affordable Care Act in immediately available funds.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the Parenteral Drug Association today announced the publication of Quality by Design: Putting Theory into Practice, written to help companies maximize product quality and safety. As increasing regulatory pressure is being placed on biopharmaceutical companies to be accountable for Quality Systems, the book serves as a definitive source on the interpretation and implementation of Quality by Design approaches.
In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons, researchers sought to evaluate the clinical, radiographic and functional outcomes of a Charnley total hip replacement (THR)─ a traditional hip prosthesis consisting of a polyethylene acetabular (plastic) cup and a metal femoral head─in patients under age 50 at a minimum of 35 years after the initial surgery.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its subsidiary, Biospherics Incorporated, has been awarded $469,479 under HR: 3590 – Patient Protection and Affordable Care Act in immediately available funds.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristophe Jemel Karami, DO, MS Po Box 64286, Baltimore, MD 21264-4286 Ph: (410) 955-6406 | Dr Kristophe Jemel Karami, DO, MS 601 N Caroline St, Baltimore, MD 21287-0006 Ph: (410) 955-6406 |
News Archive
Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the Parenteral Drug Association today announced the publication of Quality by Design: Putting Theory into Practice, written to help companies maximize product quality and safety. As increasing regulatory pressure is being placed on biopharmaceutical companies to be accountable for Quality Systems, the book serves as a definitive source on the interpretation and implementation of Quality by Design approaches.
In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons, researchers sought to evaluate the clinical, radiographic and functional outcomes of a Charnley total hip replacement (THR)─ a traditional hip prosthesis consisting of a polyethylene acetabular (plastic) cup and a metal femoral head─in patients under age 50 at a minimum of 35 years after the initial surgery.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its subsidiary, Biospherics Incorporated, has been awarded $469,479 under HR: 3590 – Patient Protection and Affordable Care Act in immediately available funds.
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 4 days ago
Dr. Whitney Erin Parker, MD, PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe Street, Phipps 554, Baltimore, MD 21287 Phone: 410-955-7851 Fax: 410-367-3255 | |
Dr. Richard Louis Cohen, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Cornelius Ct, Baltimore, MD 21208 Phone: 410-764-3100 | |
Dr. William Wallace Ashley Jr., M.D., PH.D., M.B.A. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5051 Greenspring Ave, Suite 300, Baltimore, MD 21209 Phone: 410-601-4417 Fax: 410-601-7138 | |
Dr. James Edmond Conway, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5051 Greenspring Ave, Suite 101, Baltimore, MD 21209 Phone: 410-664-3680 Fax: 410-664-3686 | |
Dr. Daniel Michael Sciubba, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Meyer Building 8-161, Baltimore, MD 21287 Phone: 410-491-8330 Fax: 410-502-5768 | |
Hatem S Abdo, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 19 Fontana Ln, Ste 206, Baltimore, MD 21237 Phone: 410-391-6904 Fax: 410-686-6640 | |
Omar Akram Zalatimo, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2700 Quarry Lake Dr, Suite 360, Baltimore, MD 21209 Phone: 410-486-0090 Fax: 410-486-0093 |